DOST to conduct VCO study in Valenzuela City

enablePagination: false
maxItemsPerPage: 10
totalITemsFound:
maxPaginationLinks: 10
maxPossiblePages:
startIndex:
endIndex:

Metro Manila (CNN Philippines, December 4) — Another study on the impact of virgin coconut oil on suspected COVID-19 patients will be conducted in Valenzuela City, Science and Technology Secretary Fortunato dela Peña said Friday.

“Another VCO study will be made in Valenzuela, similar to Sta. Rosa,” dela Peña said in an interview with CNN Philippines. However, other details were not finalized yet.

Researchers from the DOST-Food and Nutrition Research Institute tested the effectiveness of VCO on 57 probable and suspected cases at the Santa Rosa Community Quarantine Facility and Santa Rosa Community Hospital for 28 days.

Twenty-nine participants received standard meals with VCO, while the other 28 cases got the same meals without VCO. The VCO group was free of symptoms on the 18th day, while the control group only stopped exhibiting symptoms on the 23rd day.

“Nakawala ng symptoms at pangalawa, walang nag-deteriorate into moderate or severe cases kaya ang conclusion ng FNRI — nakabuti ang VCO,” dela Peña told The Source.

[Translation: It relieved symptoms and secondly, the condition of the participants did not deteriorate into moderate or severe cases. So the conclusion of FNRI was that VCO was helpful.]

DOST-FNRI researchers concluded that the VCO could be taken as a supplement by suspected COVID-19 patients.

Further studies needed

Health Undersecretary Maria Rosario Vergerie said Friday more research is needed to determine VCO effectiveness in suspect and probable COVID-19 cases.

“In spite of the initial results sa unang study na ginawa ng Department of Science and Technology, kailangan pa po natin ng further study para masabi natin na katanggap-tanggap itong VCO as an adjunct therapy for COVID-19,” Vergerie said in an online briefing.

[Translation: In spite of the initial results of the first study done by the Department of Science and Technology, there is a need for further study to conclude that the VCO can be an adjunct therapy for COVID-19 is acceptable.]

Meanwhile, the DOST-funded in-vitro clinical studies conducted in Singapore also showed that the substances in VCO could help fight the coronavirus.

"Kaya nilang sirain ang virus. [They can destroy the virus.] But the trials were done on low concentration of virus," dela Peña said.